Parameters | Without AC indication (n = 102) | With AC indication (n = 55) | ||
---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
Univariate analysis | ||||
Age | 1.054 (0.974–1.141) | 0.193 | 1.042 (1.005–1.081) | 0.026 |
Sex (Male) | N.C | 1.348 (0.599–3.033) | 0.471 | |
Location (Lower) | N.C | 0.816 (0.402–1.656) | 0.574 | |
Surgery (TG) | 0.541 (0.065–4.494) | 0.570 | 0.722 (0.346–1.504) | 0.384 |
Lymph node dissection (D2) | 0.553 (0.107–2.853) | 0.480 | 0.760 (0.368–1.570) | 0.458 |
Synchronous multiple GCs (Yes) | 3.551 (0.688–18.330) | 0.130 | 0.455 (0.108–1.919) | 0.284 |
Macroscopic type (3 + 4) | 4.844 (0.582–40.310) | 0.144 | 0.763 (0.376–1.548) | 0.453 |
Depth of tumor invasion | 2.382 (1.084–5.230) | 0.031 | 1.678 (0.945–2.981) | 0.077 |
Histology (por sig nec) | 0.652 (0.127–3.361) | 0.609 | 0.736 (0.316–1.716) | 0.478 |
Cancer stromal volume (sci) | 2.144 (0.393–11.710) | 0.379 | 1.090 (0.537–2.214) | 0.811 |
Tumor infiltration pattern (INFc) | 1.083 (0.210–5.582) | 0.924 | 0.694 (0.336–1.432) | 0.322 |
VI grade | 3.199 (1.624–6.302) | 0.001 | 2.319 (1.497–3.593) | < 0.001 |
Lymphatic invasion (Yes) | 3.865 (0.865–17.277) | 0.077 | N.C | |
Nodal metastasis | 2.664 (1.106–6.415) | 0.029 | 1.370 (0.884–2.125) | 0.159 |
Resection margin status (R1 + R2) | N.C | 2.047 (0.830–5.046) | 0.120 | |
pTNM stage | 5.984 (1.338–26.767) | 0.019 | 1.577 (0.646–3.847) | 0.317 |
Neoadjuvant chemotherapy (Yes) | N.C | 0.835 (0.113–6.157) | 0.860 | |
Adjuvant chemotherapy (Yes) | 9.875 (2.200–44.334) | 0.003 | 0.315 (0.130–0.760) | 0.010 |
Multivariate analysis | ||||
Age | N.A | 1.011 (0.966–1.059) | 0.631 | |
Depth of tumor invasion | N.A | 1.581 (0.804–3.107) | 0.184 | |
VI grade | 2.688 (1.240–5.825) | 0.012 | 1.918 (1.137–3.237) | 0.015 |
pTNM stage | 2.273 (0.413–12.494) | 0.345 | N.A | |
Adjuvant chemotherapy (Yes) | N.A | 0.387 (0.137–1.091) | 0.073 |